The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Nano-X Imaging Ltd. for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company’s securities between June 17, 2021 and August 18, 2021, inclusive (the ”Class Period”), are encouraged to contact the firm before December 6, 2021.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at firstname.lastname@example.org.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. The 510(k) application submitted by Nanox for the Nanox.ARC was deficient. Based on this deficiency, the FDA was unlikely to approve the application as submitted. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Nanox, investors suffered damages.
The Schall Law Firm
Brian Schall, Esq.,